Diagnos Laboratorium Utama Tbk. vs Indonesia Prima Property Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Indonesia Prima Property Tbk trades at Rp985 (market cap 2.89T, 5.2K 24h volume). The key difference: Indonesia Prima Property Tbk is far larger — about 9.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (41.7K versus 5.2K). Which is the better fit depends on your goals.
| DGNS | OMRE | |
|---|---|---|
Market Cap | 316.25B | 2.89T |
Volume | 41.7K | 5.2K |
Lot | 417 | 52 |
Turnover | 9.66M | 5.08M |
Average Price | 231.65 | 977.21 |
Value | 9.66M | 5.08M |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 2.4K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Indonesia Prima Property Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on notarial deed No. 31 dated April 23, 1983 of Sastra Kosasih, S.H., notary in Surabaya. PT Ometraco Realty, is a member of the Ometraco Group. The company operates in developing and managing apartments, office properties, hotels and shopping centers.
Read more on OMRE →